Source: San Jose Mercury News
Posted: May 14, 2008 02:43:24 PM PDT
Summary:
The San Jose Mercury News reports the Food and Drug Administration put a proposed human clinical trial by Geron Corporation, a biotechnology company in the field of stem cell research, using embryonic stem cells to attempt to treat spinal cord injuries on hold:
"Geron suffered a setback Wednesday when regulators put the brakes to its quest to become the first company to test people with a treatment developed from human embryonic stem cells. Executives with the Menlo Park biotech company said they received word from the U.S. Food and Drug Administration that the agency had placed a so-called clinical hold on their proposed test of the treatment for people with spinal injuries."
